bioRxivPharmacology & ToxicologyPreprint
Hippocampal Concentrations Drive Seizures in a Rat Model for Cefepime-induced Neurotoxicity
E. Lesnicki, G. Pais, S. Marianski, K. Valdez, Z. Gibson, J. Christopher, M. H. Scheetz
Abstract
BackgroundIn high dose, cefepime causes neurotoxicity in patients with kidney injury; however, the relationship between exposure and observed neurotoxicity is not clear, and no animal model presently recapitulates the human condition. ObjectivesThis study sought to describe plasma and tissue pharmacokinetics and pharmacodynamics (PK/PD) of cefepime in rats experiencing neurotoxicity. MethodsMale Sprague-Dawley rats (n=21) received escalating cefepime total daily doses ranging from 531-1593 mg/kg body weight/day administered as a short infusion (0.5 mL/min) every 24h for 5 days. Cefepime was quantified in plasma, cerebral cortex and hippocampus via liquid chromatography-tandem mass spectrometry (LC-MS/MS). Multiple PK/PD models of cefepime transit between plasma and brain compartments (i.e. cerebral cortex and hippocampus) and neurotoxic response were explored using Monolix 2021R1 (LixoftPK). ResultsExposure estimation of cerebral cortex demonstrated a median (IQR) AUC0 -24 and Cmax 0 -24 of 181.8 (85.2-661.3) mg {middle dot} 24 h/liter and 13.9 (1.0-30.1) mg/L, respectively. The median cerebral cortex/blood percentage of penetration was 1.7%. Exposure estimation of hippocampus demonstrated a median (IQR) AUC0 -24 and Cmax 0 -24 of 291.4 (126.6-1091.6) mg {middle dot} 24 h/liter and 8.8 (3.4-33.4) mg/L, respectively. The median hippocampus/blood percentage of penetration was 4.5%. Rats that reached a cefepime Cmax of {square}17 mg/L in the hippocampus exhibited signs of neurotoxicity. A hippocampal cefepime concentration of 4.1 {micro}g/100 mg brain tissue best described seizure stages >1 for cefepime-induced neurotoxicty. ConclusionsA cefepime plasma AUC0 -24 of 28,000 mg*24h/L and hippocampal concentrations of 4.1 {micro}g/100 mg brain tissue may be a threshold for cefepime-induced neurotoxicity. This model provides a methodology for future interrogation of the relationship between plasma concentrations, brain tissue concentrations, and neurotoxicity.
- organism: rat
- assay: bulk RNA-seq
- research focus: phylogenetics / evolution
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Use of Therapeutic Drug Monitoring to Characterize Cefepime-Induced Neurotoxicity
V. Venugopalan, C. Nys, … K. P. Klinker·bioRxiv·Aug 13, 2020
- Increased susceptibility for pathogenesis of post-traumatic epilepsy in offspring exposed to deltamethrin during gestation and ameliorative effects of dietary curcumin
Prince Kumar, Kamendra Kumar, Deepak Sharma·bioRxiv·Dec 3, 2023
- Assessment of pharmacokinetics, safety, and neuroprotective efficacy of an adjunct intramuscular verapamil therapy in a rat model of organophosphate DFP-induced status epilepticus
Yam Nath Paudel, Robert E. Blair, … Laxmikant S. Deshpande·bioRxiv·Jun 25, 2025
- Spatial and Amplitude Dynamics of Neurostimulation: Insights from the Acute Intrahippocampal Kainate Seizure Mouse Model
Thomas J. Foutz, Nicholas R. Rensing, … Michael Wong·Epilepsia OpenPeer-reviewed·Nov 6, 2023
- In vivo longitudinal mapping of brain iron accumulation after pilocarpine-induced status epilepticus
Franco Moscovicz, Leonardo Vázquez‐Morales, … Hiram Luna‐Munguía·Molecular NeurobiologyPeer-reviewed·Jan 1, 2026
- Semiology, clustering, periodicity and natural history of seizures in an experimental visual cortical epilepsy model
Bao‐Luen Chang, Marco Leite, … Robert C. Wykes·Disease Models & MechanismsPeer-reviewed·Jan 1, 2018